Medical specialists from Canada tagged as investigators in clinical trials studying Renal Cell Carcinoma
Total 18 results
-
Aly-Khan Lalani, MDSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre
Trials:- NCT04090710 (Principal Investigator)
Conditions: -
Amit OzaSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre - University Health Network
- Ontario, Toronto, Princess Margaret Hospital
- Ontario, Toronto, University Health Network - Princess Margaret Hospital
- Ontario, Toronto, University health Network (UHN)-University of Toronto
Trials:- NCT05483933 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Fallopian Tube Cancer;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Peritoneal Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Antonio Finelli, MD MSc FRCSCSeen in:
- Ontario, Toronto, University Health Network, Princess Margaret Hospital
Trials:- NCT04005183 (Principal Investigator)
Conditions: -
Craig ErkerSeen in:
- Nova Scotia, Halifax, IWK Health Centre
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT03871257 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03126916 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT05602194 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT04089358 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Medulloblastoma;
- Neurofibromatosis Type 1;
- Low Grade Glioma;
- Visual Pathway Glioma;
- Low Grade Astrocytoma;
- Metastatic Low Grade Astrocytoma;
- Metastatic Low Grade Glioma;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Glioblastoma;
- Malignant Glioma;
- Anaplastic Astrocytoma;
- Anaplastic Astrocytoma, Not Otherwise Specified;
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Glioblastoma, Not Otherwise Specified;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Neuroblastoma;
- Ganglioneuroblastoma;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Lymphoblastic Lymphoma;
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1;
- B Acute Lymphoblastic Leukemia, BCR-ABL1-Like;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Hematopoietic and Lymphoid Cell Neoplasm
-
Darin Gopaul, MDSeen in:
- Ontario, Kitchener, Grand River Hospital, Grand River Regional Cancer Centre
- Ontario, Kitchener, Grand River Regional Cancer Centre
Trials:- NCT03127631 (Principal Investigator)
- NCT04090710 (Principal Investigator)
-
David B. DixSeen in:
- British Columbia, Vancouver, British Columbia Children's Hospital
Trials:- NCT02724579 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03126916 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898755 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT00772200 (Principal Investigator)
Conditions:- Medulloblastoma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Neuroblastoma;
- Ganglioneuroblastoma;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Acute Myeloid Leukemia;
- Soft Tissue Sarcoma;
- Lymphoma;
- Leukemia;
- Osteosarcoma;
- Ewing Sarcoma;
- Rhabdoid Tumor;
- Retinoblastoma;
- Rhabdomyosarcoma;
- Malignant Neoplasm;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Childhood Malignant Neoplasm
-
Derek JonkerSeen in:
- Ontario, Ottawa, Ottawa Hospital Cancer Centre
- Ontario, Ottawa, Ottawa Hospital Cancer Centre (OHRI)
Trials:- NCT04260802 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Diane ProvencherSeen in:
- Quebec, Montréal, CHUM - University of Montreal Hospital Centre
- Quebec, Montréal, Centre Hospitalier de l'Universite de Montreal (CHUM)
- Quebec, Montréal, Centre Hospitalier de l'Université de Montréal
Trials:- NCT05456685 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05329545 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- High Grade Serous Ovarian Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Donna L. JohnstonSeen in:
- Ontario, Ottawa, Children's Hospital of Eastern Ontario
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03126916 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT00772200 (Principal Investigator)
- NCT03223753 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Medulloblastoma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Neuroblastoma;
- Ganglioneuroblastoma;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Embryonal Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Childhood Malignant Neoplasm;
- Hematopoietic and Lymphatic System Neoplasm
-
Douglas R. StrotherSeen in:
- Alberta, Calgary, Alberta Children's Hospital
Trials:- NCT01790152 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT00772200 (Principal Investigator)
Conditions:- Osteosarcoma;
- Lymphoblastic Lymphoma;
- Recurrent Lymphoma;
- Recurrent Malignant Neoplasm;
- Hodgkin Lymphoma in Remission;
- Leukemia in Remission;
- Recurrent Leukemia;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Congenital Mesoblastic Nephroma;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Anaplastic Kidney Wilms Tumor;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Ganglioneuroblastoma;
- Stage 4 Neuroblastoma;
- Childhood Malignant Neoplasm
-
Lisa A. GoodyearSeen in:
- Newfoundland and Labrador, Saint John's, Janeway Child Health Centre
Trials:- NCT04759586 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03126916 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT03223753 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Medulloblastoma;
- Low Grade Glioma;
- Low Grade Astrocytoma;
- Metastatic Low Grade Astrocytoma;
- Metastatic Low Grade Glioma;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Neuroblastoma;
- Ganglioneuroblastoma;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Mixed Phenotype Acute Leukemia;
- Hematopoietic and Lymphatic System Neoplasm
-
Mariana P. SilvaSeen in:
- Ontario, Kingston, Kingston Health Sciences Centre
Trials:- NCT00898365 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Congenital Mesoblastic Nephroma;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Anaplastic Kidney Wilms Tumor;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Ganglioneuroblastoma;
- Stage 4 Neuroblastoma;
- Childhood Malignant Neoplasm
-
Naveen Bassappa, MDSeen in:
- Alberta, Edmonton, Cross Cancer Institute
Trials:- NCT04090710 (Principal Investigator)
Conditions: -
Quincy ChuSeen in:
- Alberta, Edmonton, Cross Cancer Institute
- Alberta, Edmonton, GSK Investigational Site
Trials:- NCT04260802 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT03739710 (Principal Investigator)
- NCT06077877 (Principal Investigator)
Conditions:- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Sarah J. McKillopSeen in:
- Alberta, Edmonton, University of Alberta Hospital
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT04089358 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Hematopoietic and Lymphoid Cell Neoplasm;
- Childhood Malignant Neoplasm
-
Scott Morgan, MDSeen in:
- Ontario, Ottawa, The Ottawa Regional Cancer Centre
Trials:- NCT04090710 (Principal Investigator)
Conditions: -
William Chu, MDSeen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre- Odette Cancer Centre
Trials:- NCT04090710 (Principal Investigator)
Conditions: -
Wilson MillerSeen in:
- Quebec, Montreal, Jewish General Hospital
- Quebec, Montreal, Jewish General Hospital - Clinical Research Unit
Trials:- NCT04260802 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
Clinical Trials on Renal Cell Carcinoma
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Unresectable Renal Cell... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Advanced Sarcomatoid Renal...United States
-
Australian and New Zealand Urogenital and Prostate...RecruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11.2 Translocation-Related Renal Cell CarcinomaAustralia
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States, Taiwan, Australia
-
Bradley A. McGregor, MDBristol-Myers Squibb; ExelixisRecruitingRenal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Collecting Duct Renal Cell Carcinoma | Translocation Renal Cell Carcinoma | Unresectable Advanced Renal Cell Carcinoma | Metastatic Ncc Renal Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingChromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma | Fumarate Hydratase Deficient Renal Cell Carcinoma | Succinate Dehydrogenase Deficient Renal Cell Carcinoma | Collecting Duct Renal...United States
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers SquibbActive, not recruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11 Translocation CarcinomaAustralia
-
Jonsson Comprehensive Cancer CenterBeiGene; Driven To CureWithdrawnMetastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Unresectable Renal Cell Carcinoma | Hereditary Leiomyomatosis and Renal Cell Carcinoma | Clear Cell Papillary Renal Neoplasm | Hereditary Papillary Renal Cell Carcinoma and other conditionsUnited States
-
Peloton Therapeutics, Inc.Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Renal Cancer | Renal Cell Carcinoma (RCC) | Renal Cell Cancer Metastatic | Kidney | Clear Cell Renal Cell Carcinoma (ccRCC) | Renal Cell Carcinoma Recurrent | Renal Cell Cancer, RecurrentUnited States